glp-1 receptor agonists in pediatric and adolescent obesity prescribing among teens with Neurobiological Mechanisms and Therapeutic Potential
Description
Weight loss was more pronounced in patients with a BMI over 35, compared to those under 35
GLP-1 receptor agonists in the treatment of type 2 diabetes state-of-the-art
NagashimaMWatanabeTTerasakiMTomoyasuMNohtomiKKim-KaneyamaJet alNative incretins prevent the development of atherosclerotic lesions in apolipoprotein E knockout mice
In vitro , Ma and colleagues [90] also showed liraglutide to reduce H 2 O 2 -related damage in RGCs through inhibition of mitophagy induction, primarily by reducing ROS and maintaining mitochondrial membrane potential
Available at: 22 RanganathLRBeetyJMMorganLMWrightJWHowlandRMarksV
